Get all your news in one place.
100's of premium titles.
One app.
Start reading
Euronews
Euronews
Gabriela Galvin

Emotional overeaters may see fewer benefits from weight loss drugs like Ozempic, study finds

People who overeat to help manage their emotions may not benefit as much from blockbuster weight loss drugs, a small study suggests.

Popular medications such as Ozempic, Wegovy, and Mounjaro belong to a class of drugs known as glucagon-like peptide-1 (GLP-1) receptor agonists, which help people lose weight by mimicking a hormone that reduces their appetite.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.